These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 29920909)
21. [Quality of life after extensive pelvic surgery]. Levý M; Lipská L; Visokai V; Šimša J Rozhl Chir; 2016; 95(9):358-462. PubMed ID: 27653304 [TBL] [Abstract][Full Text] [Related]
22. Curative pelvic exenteration: initial experience and clinical outcome. Ali Uraiqat A; Al Nsour D; Mestareehy KM; Allababdeh MS; Naffa MTF; Alrabee MM; Al-Hammouri F Pan Afr Med J; 2023; 44():170. PubMed ID: 37455871 [TBL] [Abstract][Full Text] [Related]
23. Clinical, MRI, and PET-CT criteria used by surgeons to determine suitability for pelvic exenteration surgery for recurrent rectal cancers: a Delphi study. Chew MH; Brown WE; Masya L; Harrison JD; Myers E; Solomon MJ Dis Colon Rectum; 2013 Jun; 56(6):717-25. PubMed ID: 23652745 [TBL] [Abstract][Full Text] [Related]
24. Outcomes following repeat exenteration for locally advanced pelvic malignancy. Blake J; Koh CE; Steffens D; De Robles MS; Brown K; Lee P; Austin K; Solomon MJ Colorectal Dis; 2021 Mar; 23(3):646-652. PubMed ID: 33058495 [TBL] [Abstract][Full Text] [Related]
25. Indications for primary and secondary exenterations in patients with cervical cancer. Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276 [TBL] [Abstract][Full Text] [Related]
26. Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes. Mehta AM; Hellawell G; Burling D; Littler S; Antoniou A; Jenkins JT Tech Coloproctol; 2018 Sep; 22(9):663-671. PubMed ID: 30306276 [TBL] [Abstract][Full Text] [Related]
27. Surgical, survival and quality of life outcomes in over 1000 pelvic exenterations: lessons learned from a large Australian case series. Steffens D; Solomon MJ; Lee P; Austin K; Koh C; Byrne C; Karunaratne S; Hatcher S; Taylor K; McBride K ANZ J Surg; 2023 May; 93(5):1232-1241. PubMed ID: 36869215 [TBL] [Abstract][Full Text] [Related]
29. [Microsurgical reconstruction of the pelvic floor after pelvic exenteration. Reduced morbidity and improved quality of life by an interdisciplinary concept]. Stechl NM; Baumeister S; Grimm K; Kraus TW; Bockhorn H; Exner KE Chirurg; 2011 Jul; 82(7):625-30. PubMed ID: 21161142 [TBL] [Abstract][Full Text] [Related]
30. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193 [TBL] [Abstract][Full Text] [Related]
31. Variation in outcome measurement and reporting in studies of pelvic exenteration for locally advanced and recurrent rectal cancer: a systematic review. Brown KGM; Pisaniello J; Ng KS; Solomon MJ; Sutton PA; Hatcher S; Steffens D Colorectal Dis; 2024 Feb; 26(2):272-280. PubMed ID: 38131647 [TBL] [Abstract][Full Text] [Related]
32. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer. Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530 [TBL] [Abstract][Full Text] [Related]
33. Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases. Hsu TW; Chiang FF; Chen MC; Wang HM Asian J Surg; 2011 Jul; 34(3):115-20. PubMed ID: 22208686 [TBL] [Abstract][Full Text] [Related]
35. Effect of Surgery on Health-Related Quality of Life of Patients With Locally Recurrent Rectal Cancer. Pellino G; Sciaudone G; Candilio G; Selvaggi F Dis Colon Rectum; 2015 Aug; 58(8):753-61. PubMed ID: 26163954 [TBL] [Abstract][Full Text] [Related]
36. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer. Gould LE; Pring ET; Moorghen M; Burns EM; Antoniou A; Steele CW; Roxburgh CS; Jenkins JT Eur J Surg Oncol; 2023 Nov; 49(11):106971. PubMed ID: 37442715 [TBL] [Abstract][Full Text] [Related]
37. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series. Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958 [TBL] [Abstract][Full Text] [Related]
38. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer. Platt E; Dovell G; Smolarek S Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497 [TBL] [Abstract][Full Text] [Related]
39. Survival after pelvic exenteration for T4 rectal cancer. Kusters M; Austin KK; Solomon MJ; Lee PJ; Nieuwenhuijzen GA; Rutten HJ Br J Surg; 2015 Jan; 102(1):125-31. PubMed ID: 25451182 [TBL] [Abstract][Full Text] [Related]
40. Outcomes of Pelvic Exenteration with en Bloc Partial or Complete Pubic Bone Excision for Locally Advanced Primary or Recurrent Pelvic Cancer. Austin KK; Herd AJ; Solomon MJ; Ly K; Lee PJ Dis Colon Rectum; 2016 Sep; 59(9):831-5. PubMed ID: 27505111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]